Active, not recruitingInterventionalPhase 2Phase 3Updated May 14, 2026
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination. | NCT00200694 | Trialant
TerminatedInterventionalPhase 4Updated Feb 4, 2009
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.
ClinicalTrials.gov ID
NCT00200694
Lead Sponsor
Nantes University HospitalOTHER
Overall Status
Terminated
Study Type
Interventional
Phase
Phase 4
Enrollment
18
Last Update Posted
Feb 4, 2009Estimated
Start Date
Mar 2005
Primary Completion Date
Mar 2007Actual
Completion Date
Mar 2007Actual
Brief Summary
Determine the best strategy for proteinuria lowering in patients with proteinuria > 1 g/day receiving ACEI and ARB combination: either increase of ACEI and ARB dosage or increase of diuretic dosage.